| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |